Cost-Effectiveness Analysis of Conbercept Versus Ranibizumab For The Treatment of Age-Related Macular Degeneration In China
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.558
https://www.valueinhealthjournal.com/article/S1098-3015(15)02634-0/fulltext
Title :
Cost-Effectiveness Analysis of Conbercept Versus Ranibizumab For The Treatment of Age-Related Macular Degeneration In China
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)02634-0&doi=10.1016/j.jval.2015.09.558
First page :
A421
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
475